Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Ana del Pozo Rodríguez"'
Autor:
Begoña Calvo Hernáez, Miguel Ángel Gastelurrutia Garralda, Amaia Urionagüena de la Iglesia, Arantxazu Isla Ruiz, Ana del Pozo Rodríguez, María Ángeles Solinís Aspiazu
Publikováno v:
Atención Primaria, Vol 54, Iss 1, Pp 102198- (2022)
Resumen: La colaboración interdisciplinar entre profesionales sanitarios es esencial para mejorar los resultados en salud de la población. Las capacidades que poseen los farmacéuticos les convierten en profesionales que pueden contribuir al contro
Externí odkaz:
https://doaj.org/article/36e49306623548e19bcbdc2526a63d91
Autor:
Marina Beraza-Millor, Julen Rodríguez-Castejón, Jonatan Miranda, Ana del Pozo-Rodríguez, Alicia Rodríguez-Gascón, María Ángeles Solinís
Publikováno v:
Pharmaceutics, Vol 15, Iss 7, p 1936 (2023)
Substrate reduction therapy (SRT) has been proposed as a new gene therapy for Fabry disease (FD) to prevent the formation of globotriaosylceramide (Gb3). Nanomedicines containing different siRNA targeted to Gb3 synthase (Gb3S) were designed. Formulat
Externí odkaz:
https://doaj.org/article/cd7f99f4f05048b184df3aae8ce1768f
Autor:
Xabier Aizpurua-Arruti, Amaia Malet-Larrea, Ainhoa Oñatibia-Astibia, Ana del Pozo-Rodríguez, Estibaliz Goyenechea, Miguel Ángel Gastelurrutia
Publikováno v:
Farmacéuticos Comunitarios, Vol 13, Iss 3, Pp 17-24 (2021)
Introducción: la asistencia sanitaria a domicilio es una de las estrategias que impulsan las administraciones para pacientes pluripatológicos que viven en sus domicilios y que debido a su grado de discapacidad o vulnerabilidad no pueden desplazarse
Externí odkaz:
https://doaj.org/article/6252ba7d69874683920e4e9c8eb232e4
Autor:
Alicia Rodríguez-Gascón, Ana Alarcia-Lacalle, María Ángeles Solinís, Ana del Pozo-Rodríguez, Zuriñe Abajo, María Cabero, Andrés Canut, Arantxa Isla
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1185 (2023)
Urinary tract infections (UTIs) are extremely common and a major driver for the use of antimicrobials. Calcium fosfomycin is an old antibiotic indicated for the treatment of UTIs; however, data about its urine pharmacokinetic profile are scarce. In t
Externí odkaz:
https://doaj.org/article/f276d7e9fcee48e28f89a4c5c2912526
Autor:
Julen Rodríguez-Castejón, Itziar Gómez-Aguado, Marina Beraza-Millor, María Ángeles Solinís, Ana del Pozo-Rodríguez, Alicia Rodríguez-Gascón
Publikováno v:
Nanomaterials, Vol 12, Iss 14, p 2339 (2022)
Gene supplementation therapy with plasmid DNA (pDNA) represents one of the most promising strategies for the treatment of monogenic diseases such as Fabry disease (FD). In the present work, we developed a solid lipid nanoparticles (SLN)-based non-vir
Externí odkaz:
https://doaj.org/article/201943493f674419b981fa6bb0049ea3
Autor:
Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Marina Beraza-Millor, Mónica Vicente-Pascual, Alicia Rodríguez-Gascón, Sara Garelli, Luigi Battaglia, Ana del Pozo-Rodríguez, María Ángeles Solinís
Publikováno v:
Pharmaceutics, Vol 13, Iss 9, p 1472 (2021)
The anti-inflammatory cytokine Interleukin-10 (IL-10) is considered an efficient treatment for corneal inflammation, in spite of its short half-life and poor eye bioavailability. In the present work, mRNA-based nanomedicinal products based on solid l
Externí odkaz:
https://doaj.org/article/161894298f584dfe9faeaeb70999b60c
Autor:
Julen Rodríguez-Castejón, Ana Alarcia-Lacalle, Itziar Gómez-Aguado, Mónica Vicente-Pascual, María Ángeles Solinís Aspiazu, Ana del Pozo-Rodríguez, Alicia Rodríguez-Gascón
Publikováno v:
Pharmaceutics, Vol 13, Iss 6, p 771 (2021)
Fabry disease (FD) is a monogenic X-linked lysosomal storage disorder caused by a deficiency in the lysosomal enzyme α-Galactosidase A (α-Gal A). It is a good candidate to be treated with gene therapy, in which moderately low levels of enzyme activ
Externí odkaz:
https://doaj.org/article/cd60c48d21e148e188e4165c132086ea
Autor:
Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Mónica Vicente-Pascual, Alicia Rodríguez-Gascón, Ana del Pozo-Rodríguez, María Ángeles Solinís Aspiazu
Publikováno v:
Molecules, Vol 25, Iss 24, p 5995 (2020)
The development of safe and effective nucleic acid delivery systems remains a challenge, with solid lipid nanoparticle (SLN)-based vectors as one of the most studied systems. In this work, different SLNs were developed, by combination of cationic and
Externí odkaz:
https://doaj.org/article/3723a0601046461abd7093aab0c35698
Autor:
Mónica Vicente-Pascual, Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Alicia Rodríguez-Gascón, Elisabetta Muntoni, Luigi Battaglia, Ana del Pozo-Rodríguez, María Ángeles Solinís Aspiazu
Publikováno v:
Pharmaceutics, Vol 12, Iss 6, p 584 (2020)
One of the main challenges in gene therapy is the issue of delivery, and it is especially relevant for the success of gene therapy in the cornea. In the present work, eye drops containing biocompatible non-viral vectors based on solid lipid nanoparti
Externí odkaz:
https://doaj.org/article/6948b24e6a6549b7b06f9d20c10b54e5
Autor:
Itziar, Gómez-Aguado, Julen, Rodríguez-Castejón, Marina, Beraza-Millor, Alicia, Rodríguez-Gascón, Ana, Del Pozo-Rodríguez, María Ángeles, Solinís
Publikováno v:
International review of cell and molecular biology. 372
Messenger RNA (mRNA)-therapies have recently taken a huge step toward clinic thanks to the first mRNA-based medicinal products marketed. mRNA features for clinical purposes are improved by chemical modifications, but the inclusion in a delivery syste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1d5170b2af9435cd9f262eee89c55d77
https://pubmed.ncbi.nlm.nih.gov/36064265
https://pubmed.ncbi.nlm.nih.gov/36064265